MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AKTX has $33,889K in assets. $19,509K in debts. $2,768K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
26.75%
Quick Ratio
26.75%
Cash Ratio
20.63%
Debt to Asset Ratio
57.57%
Unit: Thousand (K) dollars
Assets Breakdown
    • Other intangible assets
    • Cash
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Capital redemption reserve
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash
2,768 5,203 2,484 2,711
Restricted cash
60 60 60 60
Prepaid expenses
731 185 349 447
Other current assets
30 14 53 83
Total current assets
3,589 5,462 2,946 3,301
Goodwill
-8,430 8,430 8,430
Other intangible assets
30,300 34,000 34,000 39,180
Total assets
33,889 47,892 45,376 50,911
Accounts payable
8,641 8,770 10,844 11,607
Accrued expenses
3,328 2,342 1,623 2,468
Convertible notes, net
683 673 663 700
Notes payable, net
49 81 198 179
Notes payable - related party, net
--1,256 668
Warrant liabilities
17 61 503 866
Convertible notes, related party
---0
Other current liabilities
697 424 481 650
Total current liabilities
13,415 12,351 15,568 17,138
Derivative liability
-230 100 -
Other non-current liabilities
-31 69 128
Deferred tax liability
6,094 6,952 6,952 8,040
Total liabilities
19,509 19,564 22,689 25,306
Authorized 330,854,276,210 and 245,035,791,523 ordinary shares at september 30, 2025 and december 31, 2024, respectively issued and outstanding 65,229,461,523 and 53,186,919,523 ordinary shares at september 30, 2025 and december 31, 2024, respectively
--6,523 6,523
Additional paid-in capital
234,811 234,318 224,366 220,846
Capital redemption reserve
59,342 59,342 52,194 52,194
Accumulated other comprehensive loss
-768 -782 -1,144 -1,106
Accumulated deficit
-279,005 -264,550 -259,252 -252,852
Total shareholders equity
14,380 28,328 22,687 25,605
Total liabilities and shareholders equity
33,889 47,892 45,376 50,911
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$2,768K Prepaid expenses$731K Restricted cash$60K Other current assets$30K Other intangibleassets$30,300K Total current assets$3,589K Total assets$33,889K Total liabilities andshareholders equity$33,889K Total liabilities$19,509K Total shareholdersequity$14,380K Accumulated deficit-$279,005K Accumulated othercomprehensive loss-$768K Total currentliabilities$13,415K Deferred tax liability$6,094K Additional paid-in capital$234,811K Capital redemptionreserve$59,342K Accounts payable$8,641K Accrued expenses$3,328K Other currentliabilities$697K Convertible notes, net$683K Notes payable, net$49K Warrant liabilities$17K

Akari Therapeutics Plc (AKTX)

Akari Therapeutics Plc (AKTX)